{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:51:55Z","timestamp":1794369115065,"version":"4.9.0"},"publisher-location":"New York, NY","reference-count":107,"publisher":"Springer New York","isbn-type":[{"value":"9781441902979","type":"print"},{"value":"9781441902986","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-1-4419-0298-6_6","type":"book-chapter","created":{"date-parts":[[2009,12,2]],"date-time":"2009-12-02T18:39:41Z","timestamp":1259779181000},"page":"85-99","source":"Crossref","is-referenced-by-count":15,"title":["Bone Loss in the Spondyloarthropathies: Role of Osteoclast, RANKL, RANK and OPG in the Spondyloarthropathies"],"prefix":"10.1007","author":[{"given":"Allen P.","family":"Anandarajah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"6_CR1","first-page":"2583","volume":"27","author":"L. Sinigaglia","year":"2000","unstructured":"Sinigaglia L, Nervetti A, Mela Q et al. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian study group on bone mass in rheumatoid arthritis. J Rheumatol 2000; 27:2583\u201389.","journal-title":"J Rheumatol"},{"key":"6_CR2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF01995720","volume":"73","author":"A. Weichselbaum","year":"1878","unstructured":"Weichselbaum A. The finer changes of cartilage with fungus synovitis and caries of the joint ends (German). Archiv Pathol Anat Physiol Klin Med 1878; 73:461\u201375.","journal-title":"Archiv Pathol Anat Physiol Klin Med"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S. Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A et al. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27:361\u201368.","journal-title":"Arthritis Rheum"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.rdc.2006.07.002","volume":"32","author":"L. Sinigaglia","year":"2006","unstructured":"Sinigaglia L, Varenna M, Girasole G et al. Epidemiology of osteoporosis in rheumatic diseases. Rheum Dis Clin N Am 2006; 32:631\u201358.","journal-title":"Rheum Dis Clin N Am"},{"key":"6_CR5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","volume":"133","author":"C.N. Bernstein","year":"2000","unstructured":"Bernstein CN, Blanchard JF, Leslie W et al. The incidence of fracture among patients with inflammatory bowel disease. A population based cohort study. Ann Intern Med 2000; 133:795\u201399.","journal-title":"Ann Intern Med"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/ard.61.11.1007","volume":"61","author":"B.J. Harrison","year":"2002","unstructured":"Harrison BJ, Hutchinson CE, Adams J et al. Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis. Ann Rheum Dis 2002; 61:1007\u201311.","journal-title":"Ann Rheum Dis"},{"key":"6_CR7","first-page":"167","volume":"28","author":"B. Frediani","year":"2001","unstructured":"Frediani B, Allegri A, Falsetti P et al. Bone mineral density in patients with proriatic arthritis. J Rheumatol 2001; 28:167\u201370.","journal-title":"J Rheumatol"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1365-2141.1999.01491.x","volume":"106","author":"H.M. Massey","year":"1999","unstructured":"Massey HM, Flanagan AM. Human osteoclasts derived form CD 14-positive monocytes. Br J Haematol 1999; 106:167\u201370.","journal-title":"Br J Haematol"},{"key":"6_CR9","doi-asserted-by":"crossref","unstructured":"Teitelbaum SL. Bone resorption by osteoclasts. Science 2000:1504\u20131508.","DOI":"10.1126\/science.289.5484.1504"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"22053","DOI":"10.1074\/jbc.272.35.22053","volume":"272","author":"L.S. Holliday","year":"1997","unstructured":"Holliday LS, Welgus HG, Fliszar CJ et al. Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 1997; 272:22053\u201358.","journal-title":"J Biol Chem"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","volume":"170","author":"S.L. Teitelbaum","year":"2007","unstructured":"Teitelbaum SL. Osteoclasts: What to they do and how do they do it? Am J Pathol 2007; 170:427\u2013435.","journal-title":"Am J Pathol"},{"key":"6_CR12","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1242\/jcs.108.8.2729","volume":"108","author":"H.K. Vaananen","year":"1995","unstructured":"Vaananen HK, Horton M. The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure. J Cell Sci 1995; 108:2729\u201332.","journal-title":"J Cell Sci"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1002\/art.21343","volume":"52","author":"G. Schett","year":"2005","unstructured":"Schett G, Stolina M, Bolon B et al. Analysis of the kinetics of osteoclastogenesis in arthritic rats. Arthritis Rheum 2005; 52:3192\u2013201.","journal-title":"Arthritis Rheum"},{"key":"6_CR14","first-page":"1154","volume":"25","author":"Y. Suzuki","year":"1998","unstructured":"Suzuki Y, Nishikaku F, Nakatuka M et al. Osteoclast-like cells in murine collagen induced arthritis. J Rheumatol 1998; 25:1154\u201360.","journal-title":"J Rheumatol"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","volume":"159","author":"A.R. Pettit","year":"2001","unstructured":"Pettit AR, Ji H, von Stechow D et al. TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 2001; 159:1689\u201399.","journal-title":"Am J Pathol"},{"key":"6_CR16","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI0215582","volume":"110","author":"K. Redlich","year":"2002","unstructured":"Redlich K, Hayer S, Ricci R et al. Osteoclasts are essential for TNF-medicated joint destruction. J Clin Invest 2002; 110:1419\u201327.","journal-title":"J Clin Invest"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/art.20382","volume":"50","author":"N.A. Sims","year":"2004","unstructured":"Sims NA, Green JR, Glatt M et al. Targeting osteoclasts with zoledronic acid presents bone destruction in collagen induced arthritis. Arthritis Rheum 2004; 50:2338\u201346.","journal-title":"Arthritis Rheum"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/art.20384","volume":"50","author":"P. Herrak","year":"2004","unstructured":"Herrak P, Gortz B, Hayer S et al. Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis. Arthritis Rheum 2004; 50:2327\u201337.","journal-title":"Arthritis Rheum"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/art.1780270902","volume":"27","author":"M. Bromley","year":"1984","unstructured":"Bromley M, Woolley DE. Chondroclasts and osteoclasts at subchondral sites of erosions in the rheumatoid joint. Arthritis Rheum 1984; 27:968\u201375.","journal-title":"Arthritis Rheum"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/art.1780270804","volume":"27","author":"M. Bromley","year":"1984","unstructured":"Bromley M, Woolley DE. Histopathology of the rheumatoid lesion; identification of the cell types at sites of cartilage erosion. Arthritis Rheum 1984; 27:857\u201363.","journal-title":"Arthritis Rheum"},{"key":"6_CR21","first-page":"949","volume":"152","author":"E.M. Gravallese","year":"1999","unstructured":"Gravallese EM, Harada Y, Wang JT et al. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1999; 152:949\u201351.","journal-title":"Am J Pathol"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","volume":"43","author":"E.M. Gravellese","year":"2000","unstructured":"Gravellese EM, Manning C, Tsay A et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000; 43:250\u201356.","journal-title":"Arthritis Rheum"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/rheumatology\/35.3.213","volume":"35","author":"Y. Fujikawa","year":"1996","unstructured":"Fujikawa Y, Shingu M, Torisu T et al. Bone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium. Br J Rheumatol 1996; 35:213\u201317.","journal-title":"Br J Rheumatol"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/rheumatology\/40.6.673","volume":"40","author":"Y. Suzuki","year":"2001","unstructured":"Suzuki Y, Tsutsumi Y, Nakagawa M et al. Osteoclast-like cells in an in-vitro model of bone destruction by rheumatoid synovium. Rheumatology (Oxford) 2001; 40:673\u201382.","journal-title":"Rheumatology (Oxford)"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1073\/pnas.87.18.7260","volume":"87","author":"N. Udagawa","year":"1990","unstructured":"Udagawa N, Takahashi N, Akatsu T et al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 1990; 87:7260\u201364.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/ard.55.11.816","volume":"55","author":"Y. Fujikawa","year":"1996","unstructured":"Fujikawa Y, Sabokbar A, Neale S et al. Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis 1996; 55:816\u201322.","journal-title":"Ann Rheum Dis"},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJM199502023320506","volume":"332","author":"S.C. Manolagas","year":"1995","unstructured":"Manolagas SC, Jilka RL. Bone marrow, cytokines and bone remodeling. N Eng J Med 1995; 332:305\u201311.","journal-title":"N Eng J Med"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","volume":"15","author":"L.C. Hofbauer","year":"2000","unstructured":"Hofbauer LC, Khosla S, Dunstan CR et al. The roles of osteoprotogerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000; 15:2\u201312.","journal-title":"J Bone Miner Res"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/ard.61.12.1047","volume":"61","author":"T.N. Crotti","year":"2002","unstructured":"Crotti TN, Smith MD, Weedon H et al. Receptor activator NF-kB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis and from normal patients: semiquantitative and quantitiative analysis. Ann Rheum Dis 2002; 61:1047\u201354.","journal-title":"Ann Rheum Dis"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"D.L. Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan H-L et al. Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93:165\u201376.","journal-title":"Cell"},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/jcb.20674","volume":"97","author":"A.P. Anandarajah","year":"2006","unstructured":"Anandarajah AP, Schwarz EM. Anti-RANKL therapy for inflammatory bone disorders: Mechanisms and potential clinical applications. J Cell Biochem 2006; 97:226\u201332.","journal-title":"J Cell Biochem"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/46303","volume":"402","author":"Y.Y. Kong","year":"1999","unstructured":"Kong YY, Feige U, Sarosi I et al. Activated T-cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999; 402:304\u201309.","journal-title":"Nature"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J. Lam","year":"2000","unstructured":"lam J, Takeshita S, Barker JE et al. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000; 106:1481\u201388.","journal-title":"J Clin Invest"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","volume":"159","author":"A.R. Pettit","year":"2001","unstructured":"Pettit AR, Ji H, von Stechow D et al. TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 2001; 159:1689\u201399.","journal-title":"Am J Pathol"},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1359\/JBMR.0301233","volume":"19","author":"P. Li","year":"2004","unstructured":"Li P, Schwarz EM, O\u2019Keefe et al. RANK signaling is not required for TNF-mediated increase in CD11 (hi) osteoclast precursors but is essential for mature osteoclast formation in TNF alpha mediated inflammatory arthritis. J Bone Miner Res 2004; 19:207\u201313.","journal-title":"J Bone Miner Res"},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","volume":"43","author":"E.M. Gravallese","year":"2000","unstructured":"Gravallese EM, Manning C, Tsay A et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000; 43:250\u201358.","journal-title":"Arthritis Rheum"},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","volume":"43","author":"H. Takayanagi","year":"2000","unstructured":"Takayanagi H, Lizuka H, Juji T et al. Involvement of receptor activator of nuclear factor \u03baB ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000; 43:259\u201369.","journal-title":"Arthritis Rheum"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jama.292.4.490","volume":"292","author":"L.C. Hofbauer","year":"2004","unstructured":"Hofbauer LC, Schoppet M. Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases. JAMA 2004; 292:490\u201395.","journal-title":"JAMA"},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/36593","volume":"390","author":"M.S. Anderson","year":"1997","unstructured":"Anderson MS, Maraskovsky E, Billingsley WL et al. A homologue of the TNF receptor and its ligand enhances T-cell growth and dendritic cell function. Nature 1997; 390:175\u201379.","journal-title":"Nature"},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","volume":"96","author":"H. Hsu","year":"1989","unstructured":"Hsu H, Lacey DL, Dunstan CR et al. Tumor necrosis factor receptor family member RANK mediates osteoblast differentiation and activation by osteoprotegerin ligand. Proc Natl Acad Sci USA 1989; 96:3540\u201345.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(00)00103-3","volume":"103","author":"J.E. Fata","year":"2000","unstructured":"Fata JE, Kong YY, Li J et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000; 103:41\u201350.","journal-title":"Cell"},{"key":"6_CR42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/cncr.21978","volume":"107","author":"G. Chen","year":"2006","unstructured":"Chen G, Sircar K, Aprikian A et al. Expression of RANK\/RANKL\/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. Cancer 2006; 107:289\u201398.","journal-title":"Cancer"},{"key":"6_CR43","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","volume":"13","author":"W.C. Dougall","year":"1999","unstructured":"Dougall WC, Glaccum M, Charrier K et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999; 13:2412\u201324.","journal-title":"Genes Dev"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1359\/JBMR.040713","volume":"19","author":"R.P. Kapur","year":"2004","unstructured":"Kapur RP, Yao Z, Lida MH et al Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank. J Bone Miner Res 2004; 19:1689\u201397.","journal-title":"J Bone Miner Res"},{"key":"6_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"W.A. Simonet","year":"1997","unstructured":"Simonet WA, Lacey DL, Dunstan CR et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997; 89:309\u201319.","journal-title":"Cell"},{"key":"6_CR46","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1359\/JBMR.040713","volume":"19","author":"R.P. Kapur","year":"2004","unstructured":"Kapur RP, Yao Z, Lida MH et al Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank. J Bone Miner Res 2004; 19:1689\u201397.","journal-title":"J Bone Miner Res"},{"key":"6_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s007740200049","volume":"20","author":"A. Mizuno","year":"2002","unstructured":"Mizuno A, Kanno T, Hoshi M et al. Transgenic mice over expressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis. J Bone Miner Metab 2002; 20:337\u201344.","journal-title":"J Bone Miner Metab"},{"key":"6_CR48","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1074\/jbc.275.7.4858","volume":"275","author":"Y. Azuma","year":"2000","unstructured":"Azuma Y, Kaji K, Katogi R et al. Tumor necrosis factor alpha stimulates osteoclast differentiation of and bone resorption by osteoclasts. J Biol Chem 2000; 275:4858\u201364.","journal-title":"J Biol Chem"},{"key":"6_CR49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.berh.2006.06.010","volume":"20","author":"O. Fitzgerald","year":"2006","unstructured":"Fitzgerald O, McInnes I. Spondyloarthropathy: disease at the crossroads of immunity. Best Pract Res Clin Rheumatol 2006; 20:949\u201367.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"6_CR50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/01.bor.0000159926.42761.dd","volume":"17","author":"A.P. Anandarajah","year":"2005","unstructured":"Anandarajah AP, Ritchlin CT. Treatment update on spondyloarthropathy. Curr Opin Rheumatol 2005; 17:247\u201356.","journal-title":"Curr Opin Rheumatol"},{"key":"6_CR51","first-page":"185","volume":"20","author":"E. Demis","year":"2002","unstructured":"Demis E, Roux C, Breban M et al. Infliximab in Spondyloarthropathy\u2014influence on bone density. Clin Exp Rheumatol 2002; 20:S185\u201386.","journal-title":"Clin Exp Rheumatol"},{"key":"6_CR52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/ard.62.4.347","volume":"62","author":"F. Allali","year":"2003","unstructured":"Allali F, Breban M, Porcher R et al. Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha. Ann Rheum Dis 2003; 62:347\u201349.","journal-title":"Ann Rheum Dis"},{"key":"6_CR53","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/art.1780390513","volume":"39","author":"L.A.B. Joosten","year":"1996","unstructured":"Joosten LAB, Helsen MMA, van de Loo FAJ et al. Anticyokine treatment of established type II collagen induced arthritis in DBA\/1 mice: a comparative study using anti-TNF, anti-IL-1 alpha\/beta and IL-1Ra. Arthritis Rheum 1996; 39:797\u2013809.","journal-title":"Arthritis Rheum"},{"key":"6_CR54","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.4049\/jimmunol.163.9.5049","volume":"163","author":"L.A.B. Joosten","year":"1999","unstructured":"Joosten LAB, Helsen MMA, Saxne T et al. IL-1 alpha blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF alpha blockade only ameliorates joint inflammation. J Immunol 1999; 163:5049\u201355.","journal-title":"J Immunol"},{"key":"6_CR55","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/rheumatology\/31.12.801","volume":"31","author":"B.W. Delauren","year":"1992","unstructured":"Delauren BW, Chu CQ, Filed M et al. Localization of interleukin-1\u03b1 type 1 interleukin 1 receptor and interleukin 1 receptor antagonist in the synovial membrane and cartilage\/pannus junction rheumatoid arthritis. Br J Rheumatol 1992; 31:801\u20139.","journal-title":"Br J Rheumatol"},{"key":"6_CR56","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/ard.2004.020800","volume":"63","author":"A.L. Tan","year":"2004","unstructured":"Tan AL, Marzo-Ortega H, O\u2019Connor P et al. Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study. Ann Rheum Dis 2004; 63:1041\u201345.","journal-title":"Ann Rheum Dis"},{"key":"6_CR57","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/ard.2004.023176","volume":"64","author":"H. Haibel","year":"2005","unstructured":"Haibel H, Rudwaleit M, Listing J et al. Open label trial of anakinra in active ankylosing spondylitis over 24 weeks. Ann Rheum Dis 2005; 64:296\u201398.","journal-title":"Ann Rheum Dis"},{"key":"6_CR58","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/1529-0131(199911)42:11<2319::AID-ANR9>3.0.CO;2-G","volume":"42","author":"J. Gratacos","year":"1999","unstructured":"Gratacos J, Collado A, Pons F et al. Significant loss of bone mass in patients with earlyactive ankylosing spondylitis. Arthritis Rheum 1999; 42:2319\u201324.","journal-title":"Arthritis Rheum"},{"key":"6_CR59","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/345442a0","volume":"345","author":"H. Yoshida","year":"1990","unstructured":"Yoshida H, Hayashi S-I, Kunisada T et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990; 345:442\u201344.","journal-title":"Nature"},{"key":"6_CR60","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1136\/ard.2006.054874","volume":"65","author":"P.T. Yang","year":"2006","unstructured":"Yang PT, Kasai H, Xiao WG et al. Increased expression of macrophage colony stimulating factor in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 2006; 65:1671\u201372.","journal-title":"Ann Rheum Dis"},{"key":"6_CR61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1210\/er.21.2.115","volume":"21","author":"S.C. Manolaga","year":"2000","unstructured":"Manolaga SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000; 21:115\u201337.","journal-title":"Endocr Rev"},{"key":"6_CR62","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","volume":"42","author":"M. Chabaud","year":"1999","unstructured":"Chabaud M, Durand JM, Buchs et al. A T-cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999; 42:963\u201370.","journal-title":"Arthritis Rheum"},{"key":"6_CR63","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1172\/JCI5703","volume":"103","author":"S. Kotake","year":"1999","unstructured":"Kotake S, Udagawa T, Takahashi N et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999; 103:1345\u201352.","journal-title":"J Clin Invest"},{"key":"6_CR64","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nm0297-189","volume":"3","author":"I.B. McInnes","year":"1997","unstructured":"McInnes IB, Leung BP, Sturrock RD et al. Interleukin-15 mediated T-cell-dependent regulation of tumor necrosis factor alpha production in rheumatoid arthritis. Nat Med 1997; 3:189\u201395.","journal-title":"Nat Med"},{"key":"6_CR65","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/ard.62.4.347","volume":"62","author":"F. Allali","year":"2003","unstructured":"Allali F, Breban M, Porcher R et al. Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumor necrosis factor \u03b1. Ann Rheum Dis 2003; 62:347\u201349.","journal-title":"Ann Rheum Dis"},{"key":"6_CR66","first-page":"1883","volume":"21","author":"B. Amor","year":"1994","unstructured":"Amor B, Santos RS, Nahal R et al. Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol 1994; 21:1883\u201387.","journal-title":"J Rheumatol"},{"key":"6_CR67","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/ard.2005.037465","volume":"65","author":"R.J. Francois","year":"2006","unstructured":"Francois RJ, Neure L, Sieper J et al. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumor necrosis factor a in two patients with early disease and transforming growth factor b in three more advanced cases. Ann Rheum Dis 2006; 65:713\u201320.","journal-title":"Ann Rheum Dis"},{"key":"6_CR68","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/rheumatology\/kem098","volume":"46","author":"H. Marzo-Ortega","year":"2007","unstructured":"Marzo-Ortega H, O\u2019Connor P, Emery P et al. Sacroiliac joint biopsies in early sacroilitis. Rheumatol 2007; 46:1210\u201311.","journal-title":"Rheumatol"},{"key":"6_CR69","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J. Braun","year":"1995","unstructured":"Braun J, Bollow M, Konig H et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995; 38:499\u201305.","journal-title":"Arthritis Rheum"},{"key":"6_CR70","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/art.22060","volume":"54","author":"H. Appel","year":"2006","unstructured":"Appel H, Kuhne M, Spiekermann S et al. Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 2006; 54:2845\u201351.","journal-title":"Arthritis Rheum"},{"key":"6_CR71","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/art.21907","volume":"54","author":"H. Appel","year":"2006","unstructured":"Appel H, Kuhne M, Spiekermann S et al. Immunohistochemical analysis of hip arthritis in ankylosing spondylitis. Arthritis Rheum 2006; 54:1805\u201313.","journal-title":"Arthritis Rheum"},{"key":"6_CR72","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/1529-0131(199801)41:1<180::AID-ART24>3.0.CO;2-V","volume":"41","author":"G. Cunnane","year":"1998","unstructured":"Cunnane G, Bresnihan B, Fitzgerald O. Immunohistologic analysis of peripheral joint disease in ankylosing spondylitis. Arthritis Rheum 1998; 41:180\u201382.","journal-title":"Arthritis Rheum"},{"key":"6_CR73","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/rheumatology\/kem166","volume":"46","author":"X. Baraliakos","year":"2007","unstructured":"Baraliakos X, Listing J, Brandt H et al. Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab. Rheumatology (Oxford) 2007; 46:1450\u20133.","journal-title":"Rheumatology (Oxford)"},{"key":"6_CR74","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1136\/ard.2004.033472","volume":"64","author":"X. Baraliakos","year":"2005","unstructured":"Baraliakos X, Listing J, Rudwaleit M et al. Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab. Ann Rheum Dis 2005; 64:1462\u20136.","journal-title":"Ann Rheum Dis"},{"key":"6_CR75","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/ard.2007.071159","volume":"66","author":"G. Schett","year":"2007","unstructured":"Schett G, Landewe R, van der Heidje D. Tumor necrosis factor blockers and structural remodeling in ankylosing spondylitis: what is reality and what is fiction. Ann Rheum Dis 2007; 66:709\u201311.","journal-title":"Ann Rheum Dis"},{"key":"6_CR76","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/rheumatology\/39.1.85","volume":"39","author":"D. Mitra","year":"2000","unstructured":"Mitra D, Elvins DM, Spenden DJ et al. The prevalence of vertebral compression fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology (Oxford) 2000; 39:85\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"6_CR77","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jbspin.2003.06.002","volume":"71","author":"A. El Maghraoui","year":"2004","unstructured":"El Maghraoui A. Osteoporosis and ankylosing spondylitis. Joint Bone Spine 2004; 71:291\u201395.","journal-title":"Joint Bone Spine"},{"key":"6_CR78","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S0140-6736(89)92932-2","volume":"11","author":"R. Will","year":"1989","unstructured":"Will R, Bhalla AK, Palmer R et al. Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 1989; 11:1483\u201385.","journal-title":"Lancet"},{"key":"6_CR79","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/1529-0131(199911)42:11<2319::AID-ANR9>3.0.CO;2-G","volume":"42","author":"J. Gratacos","year":"1999","unstructured":"Gratacos J, Collado A, Pons F et al. Significant loss of bone in patients with early active ankylosing spondylitis. Arthritis Rheum 1999; 42:2319\u201324.","journal-title":"Arthritis Rheum"},{"key":"6_CR80","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/rheumatology\/kel072","volume":"45","author":"H.-R. Kim","year":"2006","unstructured":"Kim H-R, Kim H-Y, Lee S-H. Elevated levels of soluble receptor activator of nuclear factor-\u03bbB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS). Rheumatology 2006; 45:1197\u201300.","journal-title":"Rheumatology"},{"key":"6_CR81","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/ard.61.12.1047","volume":"61","author":"T.N. Crotti","year":"2002","unstructured":"Crotti TN, Smith MD, Weedon H et al. Receptor activator NF-kB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis and from normal patients: semiquantitative and quantitative analysis. Ann Rheum Dis 2002; 61:1047\u201354.","journal-title":"Ann Rheum Dis"},{"key":"6_CR82","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/rheumatology\/keg047","volume":"42","author":"D.R. Haynes","year":"2003","unstructured":"Haynes DR, Barg E, Crotti TN et al. Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatol 2003; 42:123\u201334.","journal-title":"Rheumatol"},{"key":"6_CR83","first-page":"2236","volume":"31","author":"H. Franck","year":"2004","unstructured":"Franck H, Meurer T, Hofbauer LC. Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol 2004; 31:2236\u201341.","journal-title":"J Rheumatol"},{"key":"6_CR84","first-page":"1430","volume":"29","author":"J. Grisar","year":"2002","unstructured":"Grisar J, Bernecker PM, Aringer M et al. Ankylosing spondylitis, psoriatic arthritis and reactive arthritis show increased bone resorption, but differ with regard to bone formation. J Rheumatol 2002; 29:1430\u201336.","journal-title":"J Rheumatol"},{"key":"6_CR85","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1002\/art.10562","volume":"46","author":"R.P. Golmia","year":"2002","unstructured":"Golmia RP, Sousa BD, Scheinberg MA. Increased osteoprotegerin and decreased pyridinoline levels in patients with ankylosing spondylitis: comment on the article by Gratacos et al. Arthritis Rheum 2002; 46:3390\u201391.","journal-title":"Arthritis Rheum"},{"key":"6_CR86","first-page":"127","volume":"62","author":"D.D. Gladman","year":"1987","unstructured":"Gladman DD, Schukett R, Russell ML et al. QJ Med 1987; 62:127\u201341.","journal-title":"QJ Med"},{"key":"6_CR87","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/rheumatology\/30.4.245","volume":"30","author":"J.C. Torre Alonso","year":"1991","unstructured":"Torre Alonso JC, Perez RA, Castrillo AJM et al. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 1991; 30:245\u201350.","journal-title":"Br J Rheumatol"},{"key":"6_CR88","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","volume":"42","author":"D. Kane","year":"2003","unstructured":"Kane D, Stafford L, Bresnihan B et al. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheuamtology (Oxford) 2003; 42:1460\u201368.","journal-title":"Rheuamtology (Oxford)"},{"key":"6_CR89","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI200316069","volume":"111","author":"C.T. Ritchlin","year":"2003","unstructured":"Ritchlin CT, Haas-Smith SA, Li P et al. Mechanisms of anti-TNF-alpha and RANKL mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003; 111:821\u201331.","journal-title":"J Clin Invest"},{"key":"6_CR90","unstructured":"Anandarajah AP, Schwarz EM, Totterman S et al. The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow edema in patients with psoriatic arthritis. Ann Rheum Dis (in press)."},{"key":"6_CR91","first-page":"1726","volume":"52","author":"S.M. Reddy","year":"2005","unstructured":"Reddy SM, Reed G, Anandarajah AP et al. Comparative analysis of disease activity, radiographic features and bone density in psoriatic and rheumatoid arthritis. Arthritis Rheum 2005; 52:S1726.","journal-title":"Arthritis Rheum"},{"key":"6_CR92","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1572-0241.1999.01079.x","volume":"94","author":"M. Dinca","year":"1999","unstructured":"Dinca M, Fries W, Luisetto G et al. Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol 1999; 94:1292\u201397.","journal-title":"Am J Gastroenterol"},{"key":"6_CR93","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0889-857X(05)70042-9","volume":"24","author":"F. Keyser De","year":"1998","unstructured":"De Keyser F, Elewant D, De Vos M et al. Bowel inflammation and the spondyloarthropathies. Rheum Dis Clin North Am 1998; 24:785\u201313.","journal-title":"Rheum Dis Clin North Am"},{"key":"6_CR94","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1053\/gast.1996.v111.pm8898640","volume":"111","author":"C.L. Lin","year":"1996","unstructured":"Lin CL, Moniz C, Chambers TJ et al. Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology 1996; 111:1263\u201371.","journal-title":"Gastroenterology"},{"key":"6_CR95","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1074-7613(03)00326-1","volume":"19","author":"A.J. Ashcroft","year":"2003","unstructured":"Ashcroft AJ, Cruickshank SM, Croucher PI et al. Colonic dendritic cells, intestinal inflammation and T-cell mediated bone destruction are modulated by recombinant osteoportogerin. Immunity 2003; 19:849\u201361.","journal-title":"Immunity"},{"key":"6_CR96","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1568010033484197","volume":"2","author":"I.J. Fuss","year":"2003","unstructured":"Fuss IJ. Cytokine network in inflammatory bowel disease. Curr Drug Targets Inflamm Allerhy 2003; 2:101\u201312.","journal-title":"Curr Drug Targets Inflamm Allerhy"},{"key":"6_CR97","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1365-2249.2002.01798.x","volume":"128","author":"M. Westerholm-Ormio","year":"2002","unstructured":"Westerholm-Ormio M, Garioch J, Ketola I et al. Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease. Clin Exp Immunol 2002; 128:94\u201301.","journal-title":"Clin Exp Immunol"},{"key":"6_CR98","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1365-2036.2004.02097.x","volume":"20","author":"B.M. Ryan","year":"2004","unstructured":"Ryan BM, Russel MG, Schurgers L et al. Effect of antitumor necrosis factor-alpha therapy on bone turnover in patients with active Crohn\u2019s disease: a prospective study. Aliment Pharmacol Ther 2004; 20:851\u201357.","journal-title":"Aliment Pharmacol Ther"},{"key":"6_CR99","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1196\/annals.1346.055","volume":"1068","author":"M. Pazianas","year":"2006","unstructured":"Pazianas M, Rhim AD, Weinberg AM et al. The effect of anti-TNF-\u03b1 therapy on spinal bone mineral density in patients with Crohn\u2019s disease. Ann NY Acad Sci 2006; 1068:543\u201346.","journal-title":"Ann NY Acad Sci"},{"key":"6_CR100","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/gut.2004.044370","volume":"54","author":"A.R. Moschen","year":"2005","unstructured":"Moschen AR, Kaser A, Enrich B et al. The RANKL\/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut 2005; 54:479\u2013487.","journal-title":"Gut"},{"key":"6_CR101","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S8756-3282(98)00178-1","volume":"24","author":"T. Kemppainen","year":"2002","unstructured":"Kemppainen T, Kroger H, Janatuinen E et al. Osteoporosis in adult patients with celiac disease. Bone 2002; 24:249\u2013255.","journal-title":"Bone"},{"key":"6_CR102","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3109\/00365529509093307","volume":"30","author":"M. Kontakou","year":"1996","unstructured":"Kontakou M, Przemiosio RT, Sturgess RP et al. Expression of tumor necrosis factor-alpha, interleukin-6 and interleukin-2 mRNA in the jejunum of patients with celiac disease. Scand J Gastroenterol 1996; 30:456\u2013463.","journal-title":"Scand J Gastroenterol"},{"key":"6_CR103","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9270(97)00115-9","volume":"93","author":"M.C. Fornan","year":"1998","unstructured":"Fornan MC, Pedreira S, Niveloni S et al. Pre-and posttreatment serum levels of cytokines IL-1 beta, IL-6 and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia? Am J Gastroenterol 1998; 93:413\u2013418.","journal-title":"Am J Gastroenterol"},{"key":"6_CR104","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1359\/JBMR.040319","volume":"19","author":"A. Taranta","year":"2004","unstructured":"Taranta A, Fortunati D, Longo M et al. Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. J Bone Miner Res 2004; 19:1112\u20131121.","journal-title":"J Bone Miner Res"},{"key":"6_CR105","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/path.1044","volume":"196","author":"D. Baeten","year":"2002","unstructured":"Baeten D, Demetter P, Cuvelier CA et al. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathies. J Pathol 2002; 196:343\u2013350.","journal-title":"J Pathol"},{"key":"6_CR106","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/art.21643","volume":"53","author":"R.D. Inman","year":"2006","unstructured":"Inman RD, Chiu B. Early cytokine profiles in the joint define pathogen clearance and severity of arthritis in Chlamydia-induced arthritis in rats. Arthritis Rheum 2006; 53:499\u2013507.","journal-title":"Arthritis Rheum"},{"key":"6_CR107","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/rheumatology\/keh323","volume":"43","author":"I. Butrimiene","year":"2004","unstructured":"Butrimiene I, Jarmalaite S, Ranceva J et al. Different cytokine profiles in patients with chronic and acute reactive arthritis. Rheumatol 2004; 43:1300\u20131304.","journal-title":"Rheumatol"}],"container-title":["Advances in Experimental Medicine and Biology","Molecular Mechanisms of Spondyloarthropathies"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-0298-6_6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T15:22:49Z","timestamp":1685200969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4419-0298-6_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9781441902979","9781441902986"],"references-count":107,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-0298-6_6","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4419-0298-6","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}